Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron + dexamethasone versus metoclopramide + dexamethasone for chemotherapy-induced nausea and vomiting
IRCT20170902036032N1Phase 4Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chemotherapy-induced nausea and vomiting (CINV) comparing Ondansetron + dexamethasone with Metoclopramide + dexamethasone (2 arms). Primary endpoints: Severity of pain, Nausea and vomiting and 2 more. Started Dec 2017; status: completed.
02
Drugs
ondansetronmetoclopramidedexamethasone
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on IRCT20170902036032N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170902036032N1.